4[3]Pravinkumar E,Webster NR.HIT/HITT and alternative anticoagulation[J].Current Concepts, Br J Anaesth,2003,90(5),676-685.
5[5]Linda.Shore-Lesserson.New anticoagulants agents[J].Canadina Journal of Anesthesia,2004,51:R9.
6[6]Dan Longrosis,Emmanuel de Maistre,Nicolas Bischiff,et al.Recobmint hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia[J].Canadian Jounral of Anesthesia,2000,47:255-260.
7[7]Kunt Tove Lappegard,Michael Fung,Grethe Bergseth,et al.Artificial Surface-induced Cytokine Synthesis:erect of hepar in Coating and Complement inhibition[J].Ann Thorac Surg,2004,78:34-38.
8[8]Matsuo T Koide M,Kario K.Application of argatroban,direct thrombin inhibitor,in heparin-intolerant patients requiring extracorporeal[J].Arlif organ,1977,21(9)1035-1038.
9[10]Walker CPR,Royston D.Thrombin generation and its inhibition:a review of the scientific basic and mechanism of action of anticoagulant therapies[J].Br J Anaesth,2002,88(6):848-863.
10Warkentin TE, Roberts RS, Hirsh J, et al. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med, 2003, 163(20):2514-2518.
